[1] |
LIN Yi, WANG Ce, KANG Xun, KANG Zhuang, CHEN Feng, JIANG Bo, LI Wenbin.
Screening recurrent glioblastoma-related genes and analyzing their gene expressions in association with clinicopathological parameters and prognosis
[J]. China Oncology, 2022, 32(1): 13-23.
|
[2] |
XU Ran , WANG Xinyue , FENG Linyuan , HAN Anna , WANG Yixuan , YANG Wanshan , LIU Chao .
Expression and biological significance of NCAPD2 in glioma
[J]. China Oncology, 2021, 31(9): 789-798.
|
[3] |
HUANG Ling , ZOU Yourui , LI Zuoqi , MA Yue , GAO Xinyi , MA Hui .
Effect of CHKA gene silencing on biological behavior of glioma cell and its mechanism
[J]. China Oncology, 2021, 31(11): 1041-1049.
|
[4] |
HUANG Ling , ZOU Yourui , MA Yue , LI Zhuoqi , GAO Xinyi , ABU Lagu , MA Hui .
Expression difference and clinical significance of CHKα in different grades of gliomas
[J]. China Oncology, 2021, 31(10): 892-898.
|
[5] |
YANG Tongqu , HAN Zhitong , ZHAO Weiping , CHEN Yunzhao , ZHANG Dapeng , ZHANG Ruijian .
The prognostic value of microfluidic core technology in detecting circulating tumor cells in brain glioma
[J]. China Oncology, 2021, 31(10): 905-911.
|
[6] |
ZHANG Lianglong , AN Hongwei , ZHAO Lizhi , DONG Qian , GAO Guiyan .
Mechanism of overexpression of lncRNA LINC00152 in temozolomide-induced stem cell cycle arrest in glioma
[J]. China Oncology, 2020, 30(5): 328-334.
|
[7] |
KANG Qingjie, XIANG Zheng.
Glioma-associated oncogene homologue 2 promotes epithelial-mesenchymal transition in colon cancer cell line SW620
[J]. China Oncology, 2020, 30(4): 254-260.
|
[8] |
ZHU Chuanying, JIANG Mawei, ZHOU Renhua, LU Dongqing, ZHOU Qing.
Clinical study of nimotuzumab combined with chemoradiotherapy in the patients with pediatric brain stem gliomas
[J]. China Oncology, 2019, 29(9): 730-735.
|
[9] |
LIU Zheng, WANG Jing, SHEN Wei, ZHAO Shuxuan, YUAN Wenhua, ZHOU Haiyu.
Expression of EphA7 in osteosarcoma and its effect on proliferation, migration and apoptosis of osteosarcoma MG-63 cells
[J]. China Oncology, 2019, 29(3): 171-177.
|
[10] |
HUANG Limin, LEI Zhu, ZHANG Yu, LI Yong, HOU Jing, XU Zhong, CAO Hui, WANG Tao, YANG Jie.
Clinical evaluation of postoperative residual tumor by 3D-ASL magnetic resonance imaging in high-grade glioma
[J]. China Oncology, 2019, 29(11): 875-879.
|
[11] |
CHEN Jianxin, KANG Xun, LI Yan, et al.
Clinical significance of cerebrospinal fluid D-dimer in glioma patients with ventricular metastasis and spinal cord metastasis
[J]. China Oncology, 2018, 28(9): 641-648.
|
[12] |
CHEN Dikang, DING Xiaojie, ZHANG Zhenyu, et al.
single-arm phase Ⅱ clinical study of bevacizumab plus nitrosoureas treatment in patients with recurrent high-grade gliomas
[J]. China Oncology, 2018, 28(9): 649-656.
|
[13] |
XU Wenfang, FEI Yingming, ZHOU Jiankang, et al.
The role of XB130 gene in proliferation of hepatocellular carcinoma cells and its mechanism
[J]. China Oncology, 2018, 28(2): 117-122.
|
[14] |
YU Tian, LI Juan, ZHANG Weikai, et al.
Influence of down-regulation of SIRT6 expression by small interfering RNA on U2OS osteosarcoma cell line
[J]. China Oncology, 2018, 28(10): 721-725.
|
[15] |
PAN Li, TIAN Si, ZHANG Li, et al.
The role of ABCG2 in the sensitivity of glioma to pyropheophorbide-amethyl ester-mediated photodynamic therapy
[J]. China Oncology, 2017, 27(2): 81-88.
|